|

Psilocybin (drug) Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • University of California, Los Angeles1
  • Queen's University1
  • Beersheva Mental Health Center1

Indications

  • Depression2
  • Generalized Anxiety Disorder (GAD)1
  • Treatment-resistant Depression1
  • Major Depressive Diorder1
  • Anxiety1

Other2 trials

Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression
Phase 2
Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
Phase 2

Los Angeles, California1 trial

RCT of Psilocybin-assisted CBT for Depression

UCLA Semel Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.